SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-012017
Filing Date
2023-04-06
Accepted
2023-04-06 12:01:33
Documents
14
Period of Report
2023-04-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K neog-20230406.htm   iXBRL 8-K 51040
2 EX-99.1 neog-ex99_1.htm EX-99 3879
3 GRAPHIC img111031350_0.jpg GRAPHIC 7423
  Complete submission text file 0000950170-23-012017.txt   183011

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT neog-20230406.xsd EX-101.SCH 2463
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT neog-20230406_pre.xml EX-101.PRE 9896
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT neog-20230406_lab.xml EX-101.LAB 13474
8 EXTRACTED XBRL INSTANCE DOCUMENT neog-20230406_htm.xml XML 4728
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 23805086
SIC: 2835 In Vitro & In Vivo Diagnostic Substances